(Abstract)
The increasing importance of immunoglobulins G (IgGs) as biotherapeutics calls for improved structural characterization methods designed for these large (~150 kDa) macromolecules. Analysis workflows have to be rapid, robust, and require minimal sample preparation. In a previous work we showed the potential of Orbitrap Fourier transform mass spectrometry (FTMS) combined with electron transfer dissociation (ETD) for the top-down investigation of an intact IgG1, resulting in ~30% sequence coverage. Here, we describe a top-down analysis of two IgGs1 (adalimumab and trastuzumab) and one IgG2 (panitumumab) performed with ETD on a mass spectrometer equipped with a high-field Orbitrap mass analyzer. For the IgGs1, sequence coverage comparable to the previous results was achieved in a two-fold reduced number of summed transients, which corresponds, taken together with the significantly increased spectra acquisition rate, to ~six-fold improvement in analysis time. Furthermore, we studied the influence of ion-ion interaction times on ETD product ions for IgGs1, and the differences in fragmentation behavior between IgGs1 and IgG2, which present structural differences. Overall, these results reinforce the hypothesis that gas phase dissociation using both energy threshold-based and radical-driven ion activations is directed to specific regions of the polypeptide chains mostly by the location of disulfide bonds.
Introduction
Monoclonal antibodies (mAbs) are an effective therapeutic tool in a variety of medical conditions such as cancer and inflammatory disease. [1] These large glycoproteins constitute the fastest growing class of biotherapeutics. [2, 3] The main class of antibodies employed as biopharmaceuticals is immunoglobulin G (IgG). IgGs are large (~150 kDa) biomolecules with a quaternary structure made of two ~25 kDa light and two ~50 kDa heavy chains, identical among themselves, with the latter being N-glycosylated, Supporting Information Figure S1 . The four chains are interconnected and their tertiary/quaternary structure is reinforced by inter-and intra-molecular disulfide bridges. Heavy chains can be translated from different genes, and their sequence determines the so-called IgG isotype (or subclass). In the pharmaceutical industry, three of the four IgG isotypes are of interest: IgG1, IgG2, and IgG4. Although all isotypes share ~90% of homology in their amino acid sequences, the structure of their hinge regions and the disulfide bond connectivity differ significantly. IgG1 and IgG4 contain 16 disulfide bridges, two in the hinge region linking the heavy chains, one disulfide bridge linking each light chain to the corresponding heavy chain and 12 intramolecular bridges (2 and 4 for each light and heavy chain, respectively). IgG2 contains 18 disulfide bonds with four in the hinge region linking the two heavy chains together. [4, 5] Figure S1 compares the structures of an IgG1 and an IgG2. Note that the Cterminal cysteine of the light chain is linked to the third cysteine (from the Nterminus) of the heavy chain in IgG2 (and also IgG4), whereas in IgG1 it is linked to the fifth cysteine.
Due to their relevance as biotherapeutics, and with the raise of the socalled biosimilars in the pharmaceutical market, [3, 6] high-throughput and extensive characterization of the sequence and structure of IgGs is needed. [2] Mass spectrometry (MS) plays a pivotal role in analysis of IgGs. MS-based methods have been developed and implemented across all stages of mAb production. [4] The basic workflow may include intact IgG mass measurement, IgG fragment (reduced light and heavy chains or papain-produced fragments) mass measurement (referred to as middle-up MS approach), [7] middle-down, [8, 9] extended bottom-up [10] and bottom-up MS [2, 11] approaches. Although bottom-up approaches provide the most structural information today, they suffer a number of drawbacks such as artifact introduction and lengthy sample preparation. [12] [13] [14] Top-down mass spectrometry (TD MS) [15] refers to the gasphase dissociation of intact biomolecules and subsequent mass measurement of the fragmentation products. Applied to IgGs, TD MS is a convenient way to obtain primary structure information without the need of reducing the inter-chain disulfide bonds in solution. Furthermore, this approach generally allows access to sequence confirmation of terminal regions as well as variable domains. It also allows the identification and localization of major modifications and the characterization of major glycoforms. [16] It has the advantage of requiring a highly simplified sample preparation and therefore minimal artifact introduction induced by sample processing. Despite these advantages, TD MS is not yet routinely used for the characterization of mAbs, primarily due to the large number of highly charged products yielded by IgG fragmentation, which requires 6 high-resolution MS and the applications of techniques aimed at improving sensitivity, such as spectral summation (averaging). [17] Electron capture dissociation (ECD) [18, 19] and electron transfer dissociation (ETD) [20] of whole proteins usually generate larger sequence coverage than slow-heating activation methods (such as collision-induced dissociation, CID). [21] ECD and ETD MS/MS are also known as powerful methods for characterization of labile post-translational modifications, e.g., glycosylation. [22, 23] Fourier transform ion cyclotron resonance (FT-ICR) MS provides the highest resolution and can be hyphenated with ECD, making it the technique of choice for earlier TD MS experiments. [24] [25] [26] Notably, Mao et al.
achieved 25% sequence coverage of a purified IgG1 using qFT-ICR MS and ECD when isolating a single charge state in a direct infusion ionization mode. They increased the sequence coverage to ~33% with a broadband tandem mass spectrometry (MS/MS), e.g., using all the IgG1 ions present in the charge state envelope as precursors for ECD. [27] However, the general use of FT-ICR MS instruments for IgG characterization is rare, [4] presumably due to their limited presence in biopharmaceutical laboratories owing to the tedious maintenance and operational costs, as well as oftentimes low efficiency of heavy precursor ion transfer and capture in the ICR cells for subsequent ECD reaction.
With the advent of ETD efficiently performed in an external ion trap with product ion detection in a high-resolution mass analyzer, e.g., Orbitrap FTMS [28] , FT-ICR MS, [29] or time-of-flight (TOF) MS, [30, 31] the performance of TD MS has improved. Particularly, TD MS of proteins on-line separated with reversed phase liquid chromatography (LC) prior to electrospray ionization (ESI) became possible routinely. [32, 33] We have previously described the use of ETD with a high-resolution qTOF MS reporting the overall sequence coverage of 21% for mouse IgG1 and 15% for human IgG1 which provided structural information on variable domains of both the heavy and the light chain. [34] As a result of a more extensive investigation, we achieved 33% sequence coverage of a human IgG1 using ETD with a hybrid linear ion trap-Orbitrap FTMS (considering c-, zand y-type product ions) equipped with a standard (moderate electric field, D30 type) Orbitrap mass analyzer (Orbitrap Velos Pro). The results obtained with narrow (i.e., 100 m/z) and large (i.e., 600 m/z) isolation windows for precursor ions were combined to increase the final number of identified product ions. [17] In all the aforementioned TD MS studies, over one thousand (micro)scans (or transients in a time-domain domain, in the case of FTMS) were summed (averaged) to boost the sequence coverage. [17, 27, 34] Typically, several LC MS/MS runs were acquired followed by data summation (averaging) to provide the increased number of scans. The current state-of-the-art in TD MS, however, does not enable the full sequencing of the disulfide bond protected domains of light or heavy chain, neither it allows the direct localization of the glycosylation site in the C H 2 domain of the heavy chain. This is due to the compact protein structure and its disulfide bond network (see Supporting Information, Figure   S1 ), which is believed to constitute the major limitation in IgG TD MS characterization. Overall, the performance of all three approaches, using ETD on a qTOF MS or on a linear trap-Orbitrap FTMS, as well as ECD on FT-ICR MS, provide comparable results.
Here we investigated the potential of ETD implemented on a high-field compact Orbitrap FTMS, namely the Orbitrap Elite, [35] for faster top-down characterization of three therapeutic mAbs: adalimumab and trastuzumab (both of the IgG1 subclass), and the IgG2 panitumumab. The high-field Orbitrap mass analyzer is characterized by a higher frequency of ion oscillations along the central electrode compared to the prior generation of Orbitrap mass analyzers. [36, 37] Increased frequency of ion oscillations leads to the corresponding enhancement of the resolving power over a fixed acquisition time.
Moreover, the implementation of a mixed absorption and magnitude mode FT of spectral representation (known as enhanced FT, or eFT algorithm) [38] allows a further gain (of up to two-fold) in acquisition rate at a constant resolution. [39] In addition to the advantages of the employed mass analyzer, we optimized precursor ion isolation and product ion transfer between the linear trap and the Orbitrap to increase the efficiency of ETD-based TD MS. Finally, IgG TD MS was performed under the optimized conditions with a two-stage ion activation method, a combination of ETD and higher-energy collision dissociation (HCD) [40] termed EThcD, [41] which has been recently applied to TD MS experiments, demonstrating sequence complementarity with ETD. [42, 43] 
Sample delivery and ionization.
The antibodies were injected into the mass spectrometer either by on-line coupled LC or by direct infusion in a positive ion mode of ESI. In the former case, we employed an UltiMate 3000 LC system (Thermo Fisher Scientific) equipped with a reversed phase C4 column (Hypersil Gold, 1x100 mm, 5 µm particle size, Thermo Fisher Scientific, Runcorn, UK), applying a gradient of ACN from 5 to 80% in 20 min, in presence of 0.1% FA, and a flow rate of 100 µl/min generated by the loading pump. 1.5 µg of antibody (~10 pmol), diluted in 20% ACN and 0.1% FA, were typically loaded in each injection, resulting in ~2 min elution of the IgG. The IonMax ion source (Thermo Fisher Scientific) was operated at 3.7 kV, with sheath gas set to 20 and auxiliary gas to 10 arbitrary units. In the latter case, the antibody, buffer exchanged as described above, was diluted in 50% ACN and 0.1% FA to a final concentration of ~10 µM; 6 µl of this IgG solution were loaded in a 20 µl loop connected to the injection valve of the LC system and infused through a silica capillary to the nanoESI source (Nanospray Flex ion source, Thermo Fisher Scientific) equipped with a metallic emitter to which a 2.4 kV voltage was applied. The composition of the solution used to push the IgG from the loop to the source was 39.9% water, 30% ACN, 20% MeOH, 10% TFE, and 0.1% FA. The flow rate generated by the nanopump of the LC system was 0.6 µl/min. precursor ions were isolated between m/z 2400 and 2900 in the high pressure LTQ and subsequently subjected to ETD reaction. The AGC value for fluoranthene radical anions was set to 2 million charges, anion maximum injection time was set to 50 ms and ETD duration (i.e., ion-ion interaction time)
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was set either to 10 or 25 ms. Product ion detection in the Orbitrap mass analyzer was performed with 120'000 resolution (at 400 m/z, eFT enabled) and an AGC for precursor ions of 1 million charges.
For both intact mass measurements and MS/MS, the gas (N 2 ) "delta pressure" was of 0.1E-10 torr. The delta pressure corresponds to the difference in the pressure measured in the so-called ultra-high vacuum region (i.e., UHV region, or Orbitrap chamber) when nitrogen is injected into the HCD cell and when the gas is completely shut down. A delta value of 0.1E-10 torr likely corresponds to a pressure of ~1-2 mtorr of N 2 in the HCD cell. Typically the delta pressure for bottom-up proteomics (i.e., smaller size ions) is ~0.35E-10 torr.
Therefore, for TD MS the N 2 gas pressure in the HCD cell is reduced compared to the bottom-up proteomics. To further improve ion transmission to the highresolution mass analyzer from the linear trap, ions ejected from the linear trap were first collisionally cooled in the HCD cell (a technique known as "HCD trapping"), then transferred backward to the C-trap, and finally injected into the Orbitrap as previously described. [44] EThcD experiments were performed as follows. After ETD with 10 ms duration, all ETD products, including both charge-reduced species and product ions (precursors are generally completely consumed in ETD under the applied conditions), were transferred from the linear trap to the HCD cell. Here an axial potential was set to 25 or 40 V, so that instead of ion capture and relaxation a second ion activation event could occur. Finally, ions were transferred back to the C-trap and further into the Orbitrap for detection.
FTMS data processing and analysis.
The data processing routine for obtaining tandem mass spectra with an improved SNR was performed as previously described. [17] Briefly, in both LC-MS/MS and direct infusion MS/MS experiments, Orbitrap FTMS time-domain transients were recorded in MIDAS .dat format [45] and underwent summation (averaging) before being processed for time-to-frequency conversion. In this way it was possible to sum 384 ms transients derived from separate LC runs or distinct direct infusion experiments.
Enhanced Fourier transform, eFT, or a standard magnitude mode Fourier transform, mFT, was then applied to process transients and yield frequencydomain spectra (internal processing at Thermo Fisher Scientific). [38] The thus obtained frequency spectra were then converted into .RAW mass spectra (internal processing at Thermo Fisher Scientific) for further viewing and processing with XCalibur software (Thermo Fisher Scientific), as well as data analysis (vide infra).
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Final ETD mass spectra were derived from summed transients recorded for 10 and 25 ms ETD duration experiments. For an in-depth evaluation of the effect of ETD duration on IgG fragmentation, 10 and 25 ms ETD datasets were also analyzed separately. The resolution gain of eFT versus mFT is known to be twofold. [38] However, to demonstrate the practically useful and presumably sufficient resolution requirement for analysis of top-down ETD mass spectra of IgGs, only the mFT-processed data are reported here. Results obtained with eFT signal processing were found to be comparable to the mFT processing in terms of protein sequence coverage (data not shown).
Previously, the combination of Xtract deconvolution software and ProSight 
Results and discussion

Optimization of ETD MS/MS of IgG.
To maximize ETD efficiency, we sought to first optimize precursor cation selection and product ion transfer. In the Overall, the implementation of these settings allowed for SNR increases in the MS/MS mode for high m/z ions, which resulted in a reduction of the number of transients that needed to be summed to obtain high-quality mass spectra in comparison to our previous work, vide infra. Each ETD mass spectrum derived To improve the sequence coverage of the IgG1 and, specifically, of the light chain, we applied EThcD on adalimumab. We summed transients obtained with EThcD (i.e., both product ions and charge-reduced species) performed at both 25 and 40 V. As shown in Figure 2B , EThcD produced fragmentation mainly in the same areas previously covered by ETD, but also induced new cleavages at the N-terminus of both light and heavy chain, and provided b-and y-type ions from the N-terminal side of proline that could not be previously identified from ETD data. The sequence coverage for the heavy chain of adalimumab is lower than for ETD, but it passed from ~19% to ~28% for the light chain, as reported in Table 1 . Overall, the combination of 310 ETD scans and 260 EThcD scans, for a total of 570 scans, produced 30.5% sequence coverage, which is the same result obtained by averaging 1360 scans in our previous work based on the Orbitrap Velos Pro. In addition to the reduced number of scans, a two-fold scan Moreover, similarly to ECD MS/MS, [48] the ETD radical process seems to be affected by the electron transfer site, as the presence of basic residues at one side of the cleavage maxima would suggest. Finally, the shift in maxima occurring when passing from 10 to 25 ms ETD might be explained by the increased probability of secondary electron transfer events when the ETD duration is prolonged. The occurrence of secondary electron transfer and consequent charge neutralization events might be confirmed by the reduced average charge state of the product ions identified for 25 ms ETD in comparison to 10 ms ETD experiments (Table S1 , Supporting Information). The data suggest that these events are most prominent at the flexible loop and with a C H 3 domain in a compact conformation. Therefore, despite the second fragmentation event, the abundance of product ions originated within the sequence of the C H 3 domain is not higher than for the 10 ms experiments. Instead, we observe the shift between z 106 and z 86 as maxima in the disulfide-free region. Visually, this is represented in Figure 4 through a color-coded map based on crystal structure of trastuzumab (image elaborated with The PyMol Molecular Graphics System, version 1.3, Schrodinger, LLC). The passage from 10 ms to 25 ms ETD duration induces the translation of highly frequent cleavage sites (represented in red) towards the C-terminus, but still in solvent accessible positions. On the contrary, the compact "immunoglobulin-like domain" corresponding to C H 3, which resembles the structure of a beta barrel, and contains an intra-molecular disulfide bridge, remains poorly sequenced (and thus represented in black-blue).
These results reinforce the hypothesis that IgGs retain a relatively compact highorder structure in the gas phase, even under denaturing ionization conditions.
ETD MS/MS of intact human IgG2. ETD MS/MS was performed on
panitumumab, an IgG2, to provide a confirmation to our hypothesis that limitations in sequence coverage achieved for IgGs1 are mainly attributable to gas-phase retention of a structured, compact conformation by the protein. As displayed in Figure 5 , identified product ions for this IgG are localized in the areas sequenced in the experiments involving adalimumab and trastuzumab, e.g., the solvent accessible loops interconnecting consecutive disulfide-protected domains and the C H 3 domain. In-depth analysis reveals that the C-terminal portion of the heavy chain is highly sequenced, with 83 assigned z-type ions 22 versus 82 z-ions identified for trastuzumab, which has overall the highest sequence coverage for its heavy chain (Table 1) . Nevertheless, given that, in accordance to what is observed for IgGs1, the hinge region is not sequenced also in the case of panitumumab, differences between the two IgG isotypes are present in the loop interconnecting V H and C H 1. In the case of IgGs1, this loop was fully sequenced, whereas for panitumumab only partial sequencing was Orbitrap FTMS, [50] and the use of ion activation methods alternative to ETD, e.g., ultraviolet photodissociation. [51] Furthermore, improved sequence coverage is achievable by combining ETD experimental data acquired with high HCD gas pressure (i.e., maximizing light product ion transmission), and low gas pressure (i.e., maximizing heavy product ion transmission), as it results from the combination of present data with those acquired in standard operational conditions with the Orbitrap Velos Pro. Finally, the probable presence of internal products and product ions retaining parts of both light and heavy chains bonded by inter-molecular disulfide bridges will require developments in the data analysis tailoring this specific class of proteins.
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